Contact

Endocrinology Authority serves as a reference resource covering the full scope of endocrine medicine — from diagnostic frameworks and hormone disorders to treatment protocols and specialist referral criteria. This page describes how the editorial office receives and processes inquiries, what response timelines apply across different inquiry types, and what geographic scope governs the content published on this site. All content produced here draws on named regulatory and clinical sources, including guidance from the American Association of Clinical Endocrinology (AACE) and the Endocrine Society.

Response expectations

Inquiries submitted through the editorial contact form enter a triage queue reviewed on a 5-business-day cycle. The office distinguishes between four categories of incoming messages, each carrying a different processing priority:

1. Editorial corrections — requests to update factual content, flag outdated regulatory citations, or correct named source attributions. These receive the highest processing priority and are escalated within 2 business days of receipt.
2. Content suggestions — proposals for new topic pages, condition profiles, or diagnostic explainers not yet covered in the existing library. These are reviewed in the next scheduled editorial planning cycle, which runs on a 30-day cadence.
3. Licensing and syndication inquiries — requests to reproduce, adapt, or redistribute content under attribution frameworks. These are handled by the publishing operations team and carry a 10-business-day response window.
4. General information requests — background questions about methodology, sourcing standards, or site structure. These are addressed in batch during the weekly editorial review, typically within 7 business days.

No inquiry submitted through this office is reviewed by a licensed physician, nurse practitioner, or any clinical provider. Content published on Endocrinology Authority reflects publicly available clinical guidance — including standards published by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the U.S. Food and Drug Administration (FDA) — and does not constitute individualized medical guidance of any kind.

Additional contact options

Beyond the primary editorial form, the office maintains distinct pathways for specific inquiry types:

Source documentation requests: Inquiries asking for the underlying citations behind a specific claim or statistic on any page are directed to the editorial standards inbox. The office maintains a citation log for all quantified assertions, including penalty figures drawn from statutes such as 42 U.S.C. § 1320d-5 (HIPAA civil monetary penalties) and laboratory reference ranges published by the College of American Pathologists (CAP).

Academic and institutional partnerships: Universities, hospital systems, and nonprofit health organizations seeking to reference Endocrinology Authority content in educational materials may submit partnership inquiries through the licensing pathway described above. Responses from the publishing operations team include a summary of the site's sourcing methodology and permissible attribution language.

Press and media: Journalists requiring background on editorial methodology, content scope, or sourcing standards for a specific page should use the subject line prefix "MEDIA:" in the contact form. The office targets a 48-hour acknowledgment for press inquiries originating from identifiable news organizations.

How to reach this office

All contact is routed through the editorial submission form hosted on this domain. Physical mail is not accepted. Phone inquiries are not available for general editorial questions.

When submitting a message, including the following information reduces processing time:

1. The specific page URL where the issue, suggestion, or question originates
2. The category of the inquiry (correction, suggestion, licensing, general)
3. A named source or reference, if the message concerns a factual assertion
4. An organizational affiliation, if the inquiry originates from an institution

Submissions that omit the relevant page URL are categorized as general inquiries by default and processed in the 7-business-day window. The editorial office does not accept attachments from unverified senders during initial contact.

Service area covered

Endocrinology Authority publishes content calibrated to the United States regulatory and clinical environment. Condition profiles, diagnostic standards, and treatment references reflect frameworks established by agencies operating under U.S. federal jurisdiction, including the Centers for Disease Control and Prevention (CDC), the Centers for Medicare & Medicaid Services (CMS), and the National Institutes of Health (NIH).

Where applicable, content notes regulatory variation across states — for example, the 50 individual state medical licensing boards that govern endocrinology practice authority differ in their scope-of-practice definitions for advanced practice providers managing endocrine conditions. Content does not attempt to serve as a jurisdiction-specific legal or clinical compliance reference.

International readers will find the foundational science — covering topics such as how hormones regulate the body, the endocrine system, and blood tests for endocrine conditions — applicable across health systems, but all regulatory citations, drug approval statuses, and clinical threshold values reflect U.S. standards unless a page explicitly notes otherwise. Readers outside the United States should cross-reference content against the guidelines of their national health authority before drawing clinical conclusions.

Privacy Policy

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)